StockData
YD Bio Ltd logo

YD Bio Ltd (YDES) income statement

YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 5/30
$4.85+0.12 (+2.54%)

Close on Nov 18, 2026Market cap $343.33MP/E –Yield –

YD Bio Ltd income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
28.1%
Operating margin
-883.3%
Net margin
-1392.6%
Return on equity, FY2025
-445.1%

Financial strength

Current ratio
5.23
Debt to equity
–
Debt to assets
–
Cash to current liabilities
249.0%

Valuation

P/E ratio
–
Price to sales
575.26
Price to book
76.74
Dividend yield
–

See a number that looks wrong?